Article Information
PubMed
Print ISSN
Online ISSN
History
- Received May 6, 2021
- Accepted October 1, 2021
- Published online December 17, 2021.
Article Versions
- Earlier version (November 3, 2021 - 01:46).
- You are viewing the most recent version of this article.
Copyright & Usage
Copyright © 2021 by The American Society for Pharmacology and Experimental Therapeutics
Author Information
- Sean A. Misek1,
- Patrick A. Newbury1,
- Evgenii Chekalin,
- Shreya Paithankar,
- Andrea I. Doseff,
- Bin Chen,
- Kathleen A. Gallo, and
- Richard R. Neubig
- Departments of Physiology (S.A.M., A.I.D., K.A.G.), Pediatrics and Human Development (P.A.N., E.C., S.P., B.C.), and Pharmacology (A.I.D., B.C., R.R.N.), Michigan State University, East Lansing, Michigan
- Address correspondence to:
Dr. Richard R. Neubig, Michigan State University, 1355 Bogue Street, B440 Life Sciences Building, East Lansing, MI, 48824. E-mail: rneubig{at}msu.edu; or Dr. Kathleen A. Gallo, Michigan State University, 567 Wilson Road, 4164 Biomedical and Physical Sciences Building, East Lansing, MI, 48824. E-mail: gallok{at}msu.edu; or Dr. Bin Chen, Michigan State University, 1355 Bogue Street, B440 Life Sciences Building, East Lansing, MI, 48824. E-mail: chenbi12{at}msu.edu
Statistics from Altmetric.com
Article usage
In this issue
Ibrutinib Resensitizes BRAFi-Resistant Melanoma
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement